SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001328143-19-000011
Filing Date
2019-03-04
Accepted
2019-03-04 16:02:32
Documents
84
Period of Report
2018-12-31

Document Format Files

Seq Description Document Type Size
1 10-K adms1231201810k.htm 10-K 2037738
2 EXHIBIT 10.7 adms10k2018ex107.htm EX-10.7 183490
3 EXHIBIT 21.1 adms10k2018ex211.htm EX-21.1 3517
4 EXHIBIT 23.1 adms10k2018ex231.htm EX-23.1 2991
5 EXHIBIT 31.1 adms10k2018ex311.htm EX-31.1 14029
6 EXHIBIT 31.2 adms10k2018ex312.htm EX-31.2 13938
7 EXHIBIT 32.1 adms10k2018ex321.htm EX-32.1 8468
14 pipeline1a.jpg GRAPHIC 200184
  Complete submission text file 0001328143-19-000011.txt   8973615

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT adms-20181231.xml EX-101.INS 1731482
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT adms-20181231.xsd EX-101.SCH 50811
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT adms-20181231_cal.xml EX-101.CAL 89120
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT adms-20181231_def.xml EX-101.DEF 293672
12 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT adms-20181231_lab.xml EX-101.LAB 780413
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT adms-20181231_pre.xml EX-101.PRE 460026
Mailing Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608
Business Address 1900 POWELL ST., SUITE 1000 EMERYVILLE CA 94608 510-450-3554
Adamas Pharmaceuticals Inc (Filer) CIK: 0001328143 (see all company filings)

IRS No.: 421560076 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 001-36399 | Film No.: 19653679
SIC: 2834 Pharmaceutical Preparations